Medical Condition News

RSS

Lack of 'systematic reviews' in stroke research lead to waste of time, resources

Research being conducted into stroke needs to slow down and take stock if a therapeutic breakthrough is ever likely to happen, says a leading stroke expert.

14 Dec 2010

We live longer, but not healthier

Increased life expectancy in the United States has not been accompanied by more years of perfect health, reveals new research published in the December issue of the Journal of Gerontology.

14 Dec 2010

Orexo announces successful completion of OX219 initial pharmacokinetic trial for opioid dependence

Orexo AB announces successful completion of the initial pharmacokinetic trial in the OX219 project. In the comparative bioavailability study, the OX219 buprenorphine/naloxone sublingual tablet formulation demonstrated favourable profiles compared to the comparator Suboxone®, which is the market leading product for treatment of opioid dependence.

14 Dec 2010

Gore releases statement in response to safety of GORE HELEX Septal Occluder for PFO closure in cryptogenic stroke patients

W. L. Gore & Associates (Gore) today released the following statement from the Gore REDUCE Clinical Study Principal Investigators on behalf of the Gore REDUCE Clinical Study Steering Committee in response to the recent CLOSURE I results presentation.

14 Dec 2010

American Epilepsy Society recognizes neuroscientist for basic science advances

Douglas A. Coulter, Ph.D., a neuroscientist at The Children's Hospital of Philadelphia, received the 2010 Epilepsy Research Recognition Award for Basic Science from the American Epilepsy Society. The Society honored Dr. Coulter's pioneering contributions to epilepsy research on Monday, Dec. 6 at its Annual Meeting in San Antonio.

14 Dec 2010

African American patients less likely to receive medications for parkinsonian symptoms

African American patients and those with lower socioeconomic status have more advanced disease and greater disability when they seek treatment from Parkinson's disease specialists, according to a study from the University of Maryland School of Medicine.

14 Dec 2010

GTx announces Capesaris proof of concept clinical trail in men with advanced prostate cancer

BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.

14 Dec 2010

Lack of strong molecular 'glue' allows tumour cells to break away and spread

A remarkable discovery into how tumour cells invade normal tissue should lead to vital diagnostic tools and help develop strategies to stop the spread of cancer cells. A new study by scientists at the Montreal Neurological Institute and Hospital of McGill University reveals that the surface of aggressive tumour cells lack the strong molecular 'glue' responsible for binding normal cells together.

14 Dec 2010

Even small amount of alcohol increases chances of developing cancer

When raising your glass at this year's holiday toast, choose your beverage wisely, say experts at The University of Texas MD Anderson Cancer Center. If adults wish to drink alcohol, they should select drinks low in calories and alcohol content to limit cancer risk.

14 Dec 2010

$Study confirms rising rates of hip fractures in Beijing, China$

Study confirms rising rates of hip fractures in Beijing, China

A new study presented today at the 1st Asia-Pacific Osteoporosis Meeting in Singapore confirms rising rates of hip fractures in Beijing, China.

14 Dec 2010

Clinical trail shows 2009 H1N1 influenza vaccine safe and effective in asthma patients

Results from a government-sponsored clinical trial of inactivated 2009 H1N1 influenza vaccine in people with asthma indicate that a single dose of vaccine was safe and induced a strong immune response predictive of protection.

14 Dec 2010

Study finds carotid artery stenting has higher risk of stroke and death than carotid endarterectomy

To meet reimbursement criteria, candidates for carotid artery stenting (CAS) must either be high-risk surgical patients or be enrolled in a critical trial.

14 Dec 2010

Immunomedics, UCB initiate enrollment in EMBODY 1 epratuzumab Phase III study in SLE

Immunomedics Inc. and UCB today announced the enrollment of the first patient into EMBODY™ 1, one of two pivotal Phase III studies of epratuzumab in patients with moderate to severe systemic lupus erythematosus (SLE). Patient enrollment for EMBODY™ 2 has also begun.

14 Dec 2010

Vitamin D deficiency flagged as a major concern in South Asia

Bone health experts attending the 1st Asia-Pacific Osteoporosis Meeting in Singapore this week have flagged vitamin D deficiency as a major concern in the region, particularly in South Asia where the problem is especially severe and widespread across the entire population.

14 Dec 2010

Beta-catenin protein plays a key role in development of stem cells in acute leukaemia

Researchers at King's College London have discovered that leukaemic stem cells can be reversed to a pre-leukaemic stage by suppressing a protein called beta-catenin found in the blood.

14 Dec 2010

Diet linked to onset of mental illness

Changes in diet have been linked to a reduction of abnormal behaviors in mentally ill people or animals, but a Purdue University study shows that diet might also trigger the onset of mental illness in the first place.

14 Dec 2010

Reversible two-step binding mechanism to stop cancer cell growth

What makes cancer cells so dangerous is that they grow in an unregulated way and proliferate much faster than other cells. The proteasome, a large protein complex, plays a key role in this process: By breaking down used proteins for recycling, it clears the way for the next cycle.

14 Dec 2010

Medical Condition News

Lack of 'systematic reviews' in stroke research lead to waste of time, resources

We live longer, but not healthier

Orexo announces successful completion of OX219 initial pharmacokinetic trial for opioid dependence

Gore releases statement in response to safety of GORE HELEX Septal Occluder for PFO closure in cryptogenic stroke patients

American Epilepsy Society recognizes neuroscientist for basic science advances

African American patients less likely to receive medications for parkinsonian symptoms

GTx announces Capesaris proof of concept clinical trail in men with advanced prostate cancer

Lack of strong molecular 'glue' allows tumour cells to break away and spread

Even small amount of alcohol increases chances of developing cancer

Study confirms rising rates of hip fractures in Beijing, China

Clinical trail shows 2009 H1N1 influenza vaccine safe and effective in asthma patients

Study finds carotid artery stenting has higher risk of stroke and death than carotid endarterectomy

Immunomedics, UCB initiate enrollment in EMBODY 1 epratuzumab Phase III study in SLE

Vitamin D deficiency flagged as a major concern in South Asia

Beta-catenin protein plays a key role in development of stem cells in acute leukaemia

Diet linked to onset of mental illness

Reversible two-step binding mechanism to stop cancer cell growth

Study finds expression of toxic RNA that leads to Fragile X Tremor Ataxia Syndrome modifiable

National Institutes of Health honors Nevada nursing professor with $377,000 for ischemia study

Osteoporosis drug reduces bone loss in oral cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News